{"DataElement":{"publicId":"6608486","version":"1","preferredName":"Agent Dose Modification Negation Hematologic Toxicity Reason Type","preferredDefinition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect._Change, alteration, or adjustment of a dose specified in a treatment plan or/and administered to a patient._An operation in which a term denies or inverts the meaning of another term or construction._Pertaining to or related to the blood and blood-forming organs._The finding of bodily harm due to the poisonous effects of something._An explanation of the cause of some phenomenon or action._Something distinguishable as an identifiable class based on common qualities.","longName":"DS_MOD_NONHEM_TXY_TP","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"6608485","version":"1","preferredName":"Agent Dose Modification Negation Hematologic Toxicity Reason","preferredDefinition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect._Change, alteration, or adjustment of a dose specified in a treatment plan or/and administered to a patient._An operation in which a term denies or inverts the meaning of another term or construction._Pertaining to or related to the blood and blood-forming organs._The finding of bodily harm due to the poisonous effects of something._An explanation of the cause of some phenomenon or action.","longName":"6608169v1.0:6608483v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"6608169","version":"1","preferredName":"Agent Dose Modification","preferredDefinition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.:Change, alteration, or adjustment of a dose specified in a treatment plan or/and administered to a patient.","longName":"C1708:C54346","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Agent","conceptCode":"C1708","definition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Dose Modification","conceptCode":"C54346","definition":"Change, alteration, or adjustment of a dose specified in a treatment plan or/and administered to a patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F328370-B44B-0BB0-E053-F662850A83F6","latestVersionIndicator":"Yes","beginDate":"2019-01-11","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-11","modifiedBy":"ONEDATA","dateModified":"2019-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6608483","version":"1","preferredName":"Negation Hematologic Toxicity Reason","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.:Pertaining to or related to the blood and blood-forming organs.:The finding of bodily harm due to the poisonous effects of something.:An explanation of the cause of some phenomenon or action.","longName":"C25594:C62780:C27990:C25638","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Hematologic","conceptCode":"C62780","definition":"Pertaining to or related to the blood and blood-forming organs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Toxicity","conceptCode":"C27990","definition":"The finding of bodily harm due to the poisonous effects of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F35E718-34F2-305E-E053-F662850AA386","latestVersionIndicator":"Yes","beginDate":"2019-01-11","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-11","modifiedBy":"ONEDATA","dateModified":"2019-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F35E718-3503-305E-E053-F662850AA386","latestVersionIndicator":"Yes","beginDate":"2019-01-11","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-11","modifiedBy":"PROSVIROVAB","dateModified":"2019-06-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6608487","version":"1","preferredName":"Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"6608487v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Hearing loss","valueDescription":"Hearing Loss","ValueMeaning":{"publicId":"4395662","version":"1","preferredName":"Hearing Loss","longName":"4395662","preferredDefinition":"A partial or complete loss of hearing in one or both ears. It is classified as conductive, sensory, or central.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hearing Loss","conceptCode":"C35731","definition":"A partial or complete loss of hearing in one or both ears. It is classified as conductive, sensory, or central.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB79BBE-6D49-5F7C-E040-BB89AD435DD5","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7F37AF06-72AF-3F40-E053-F662850AB0B7","beginDate":"2019-01-11","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-11","modifiedBy":"ONEDATA","dateModified":"2019-01-11","deletedIndicator":"No"},{"value":"Sargramostim reaction","valueDescription":"Sargramostim Reaction","ValueMeaning":{"publicId":"6608488","version":"1","preferredName":"Sargramostim Reaction","longName":"6608488","preferredDefinition":"A recombinant therapeutic agent chemically identical to endogenous human GM-CSF except a leucine substitution in position 23.  Binding to specific cell surface receptors, sargramostim modulates the proliferation and differentiation of a variety of hematopoietic progenitor cells with some specificity towards stimulation of leukocyte production and may reverse treatment-induced neutropenias. This agent also promotes antigen presentation, up-regulates antibody-dependent cellular cytotoxicity (ADCC), and increases interleukin-2-mediated lymphokine-activated killer cell function; it may also augment host antitumoral immunity.: A response generated by a stimulus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sargramostim","conceptCode":"C1492","definition":"A recombinant therapeutic agent chemically identical to endogenous human GM-CSF except a leucine substitution in position 23.  Binding to specific cell surface receptors, sargramostim modulates the proliferation and differentiation of a variety of hematopoietic progenitor cells with some specificity towards stimulation of leukocyte production and may reverse treatment-induced neutropenias. This agent also promotes antigen presentation, up-regulates antibody-dependent cellular cytotoxicity (ADCC), and increases interleukin-2-mediated lymphokine-activated killer cell function; it may also augment host antitumoral immunity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Reaction","conceptCode":"C25637","definition":"A response generated by a stimulus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F37AF06-72BC-3F40-E053-F662850AB0B7","latestVersionIndicator":"Yes","beginDate":"2019-01-11","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-11","modifiedBy":"ONEDATA","dateModified":"2019-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7F37AF06-72D7-3F40-E053-F662850AB0B7","beginDate":"2019-01-11","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-11","modifiedBy":"ONEDATA","dateModified":"2019-01-11","deletedIndicator":"No"},{"value":"Neurotoxicity","valueDescription":"Neurotoxicity","ValueMeaning":{"publicId":"3211303","version":"1","preferredName":"Neurotoxicity","longName":"3211303","preferredDefinition":"A group of neurologic disorders caused by damage to the nervous system following exposure to pharmacologic, biologic, and chemical agents. Examples of neurotoxins include chemotherapy agents, radiation treatment, heavy metals, pesticides, and food additives.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neurotoxicity Syndrome","conceptCode":"C27961","definition":"A group of neurologic disorders caused by damage to the nervous system following exposure to pharmacologic, biologic, and chemical agents. Examples of neurotoxins include chemotherapy agents, radiation treatment, heavy metals, pesticides, and food additives.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-EAFB-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7F37AF06-72E2-3F40-E053-F662850AB0B7","beginDate":"2019-01-11","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-11","modifiedBy":"ONEDATA","dateModified":"2019-01-11","deletedIndicator":"No"},{"value":"Serum sickness","valueDescription":"Serum Sickness","ValueMeaning":{"publicId":"2944644","version":"1","preferredName":"Serum Sickness","longName":"2944644","preferredDefinition":"Delayed-type hypersensitivity reaction to foreign proteins derived from an animal serum. It occurs approximately six to twenty one days following the administration of the foreign antigen. Symptoms include fever, arthralgias, myalgias, skin eruptions, lymphadenopathy, chest pain, and dyspnea. Certain drugs (e.g., antibiotics, anticancer agents, and anti-inflammatory medications) and infectious disorders (e.g., hepatitis B) may also cause serum sickness-like reaction.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Serum Sickness","conceptCode":"C79718","definition":"Delayed-type hypersensitivity reaction to foreign proteins derived from an animal serum. It occurs approximately six to twenty one days following the administration of the foreign antigen. Symptoms include fever, arthralgias, myalgias, skin eruptions, lymphadenopathy, chest pain, and dyspnea. Certain drugs (e.g., antibiotics, anticancer agents, and anti-inflammatory medications) and infectious disorders (e.g., hepatitis B) may also cause serum sickness-like reaction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7440E944-697A-CDD0-E040-BB89AD431DF0","latestVersionIndicator":"Yes","beginDate":"2009-09-23","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-09-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7F37AF06-72EC-3F40-E053-F662850AB0B7","beginDate":"2019-01-11","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-11","modifiedBy":"ONEDATA","dateModified":"2019-01-11","deletedIndicator":"No"},{"value":"Visual changes","valueDescription":"Visual Change","ValueMeaning":{"publicId":"6608489","version":"1","preferredName":"Visual Change","longName":"6608489","preferredDefinition":"Relating to or using sight; able to be seen.: The act of alteration or modification; changed or altered in form or character.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Visual","conceptCode":"C38059","definition":"Relating to or using sight; able to be seen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Change","conceptCode":"C25446","definition":"The act of alteration or modification; changed or altered in form or character.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F37AF06-72F9-3F40-E053-F662850AB0B7","latestVersionIndicator":"Yes","beginDate":"2019-01-11","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-11","modifiedBy":"ONEDATA","dateModified":"2019-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7F37AF06-7314-3F40-E053-F662850AB0B7","beginDate":"2019-01-11","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-11","modifiedBy":"ONEDATA","dateModified":"2019-01-11","deletedIndicator":"No"},{"value":"Hyponatremia","valueDescription":"Hyponatremia","ValueMeaning":{"publicId":"4291753","version":"1","preferredName":"Hyponatremia","longName":"4291753","preferredDefinition":"Lower than normal levels of sodium in the circulating blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hyponatremia","conceptCode":"C37976","definition":"Lower than normal levels of sodium in the circulating blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8ABEA26-6341-ED7C-E040-BB89AD4312B2","latestVersionIndicator":"Yes","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7F37AF06-731E-3F40-E053-F662850AB0B7","beginDate":"2019-01-11","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-11","modifiedBy":"ONEDATA","dateModified":"2019-01-11","deletedIndicator":"No"},{"value":"Elevated creatinine/renal insufficiency","valueDescription":"Renal Failure Increased Creatinine","ValueMeaning":{"publicId":"6608490","version":"1","preferredName":"Renal Failure Increased Creatinine","longName":"6608490","preferredDefinition":"An acute or chronic condition that is characterized by the inability of the kidneys to adequately filter the blood.: A laboratory test result demonstrating an increased concentration of creatinine in a biological specimen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Renal Failure","conceptCode":"C4376","definition":"An acute or chronic condition that is characterized by the inability of the kidneys to adequately filter the blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Increased Creatinine","conceptCode":"C78249","definition":"A laboratory test result demonstrating an increased concentration of creatinine in a biological specimen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F37AF06-732B-3F40-E053-F662850AB0B7","latestVersionIndicator":"Yes","beginDate":"2019-01-11","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-11","modifiedBy":"ONEDATA","dateModified":"2019-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7F37AF06-7346-3F40-E053-F662850AB0B7","beginDate":"2019-01-11","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-11","modifiedBy":"ONEDATA","dateModified":"2019-01-11","deletedIndicator":"No"},{"value":"Capillary leak syndrome","valueDescription":"Capillary Leak Syndrome","ValueMeaning":{"publicId":"2780142","version":"1","preferredName":"Capillary Leak Syndrome","longName":"2780142","preferredDefinition":"A syndrome characterized by leakage of intravascular fluids into the extravascular space. This syndrome is observed in patients who demonstrate a state of generalized leaky capillaries following shock syndromes, low-flow states, ischemia-reperfusion injuries, toxemias, medications, or poisoning. It can lead to generalized edema and multiple organ failure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Capillary Leak Syndrome","conceptCode":"C62578","definition":"A syndrome characterized by leakage of intravascular fluids into the extravascular space. This syndrome is observed in patients who demonstrate a state of generalized leaky capillaries following shock syndromes, low-flow states, ischemia-reperfusion injuries, toxemias, medications, or poisoning. It can lead to generalized edema and multiple organ failure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"56172F89-7756-66E4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-09-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7F37AF06-7350-3F40-E053-F662850AB0B7","beginDate":"2019-01-11","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-11","modifiedBy":"ONEDATA","dateModified":"2019-01-11","deletedIndicator":"No"},{"value":"Hypotension","valueDescription":"Hypotension","ValueMeaning":{"publicId":"4395785","version":"1","preferredName":"Hypotension","longName":"4395785","preferredDefinition":"Blood pressure that is abnormally low.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypotension","conceptCode":"C3128","definition":"Blood pressure that is abnormally low.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-DB36-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7F37AF06-735A-3F40-E053-F662850AB0B7","beginDate":"2019-01-11","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-11","modifiedBy":"ONEDATA","dateModified":"2019-01-11","deletedIndicator":"No"},{"value":"Pain","valueDescription":"Pain","ValueMeaning":{"publicId":"4395777","version":"1","preferredName":"Pain","longName":"4395777","preferredDefinition":"The sensation of discomfort, distress, or agony, resulting from the stimulation of specialized nerve endings.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pain","conceptCode":"C3303","definition":"The sensation of discomfort, distress, or agony, resulting from the stimulation of specialized nerve endings.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-DA1E-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7F37AF06-7364-3F40-E053-F662850AB0B7","beginDate":"2019-01-11","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-11","modifiedBy":"ONEDATA","dateModified":"2019-01-11","deletedIndicator":"No"},{"value":"Anaphylaxis (allergic reaction/infusion reaction)","valueDescription":"Allergic Reaction Infusion Procedure Reaction Anaphylaxis","ValueMeaning":{"publicId":"6608492","version":"1","preferredName":"Allergic Reaction Infusion Procedure Reaction Anaphylaxis","longName":"6608492","preferredDefinition":"An immune response that occurs following re-exposure to an innocuous antigen, and that requires the presence of existing antibodies against that antigen. This response involves the binding of IgE to mast cells, and may worsen with repeated exposures.: Any form of treatment that is introduced into the body via a blood vessel, a muscle, or the spinal cord.: A response generated by a stimulus.: An acute hypersensitive immune response that occurs from exposure to an allergen. It results from the release of histamine and histamine-like substances from mast cells, and can present with breathing difficulty due to narrowed airways, dizziness and hypotension, skin rash, weak pulse, nausea and vomiting.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Allergic Reaction","conceptCode":"C114476","definition":"An immune response that occurs following re-exposure to an innocuous antigen, and that requires the presence of existing antibodies against that antigen. This response involves the binding of IgE to mast cells, and may worsen with repeated exposures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Infusion Procedure","conceptCode":"C15388","definition":"Any form of treatment that is introduced into the body via a blood vessel, a muscle, or the spinal cord.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Reaction","conceptCode":"C25637","definition":"A response generated by a stimulus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Anaphylaxis","conceptCode":"C107101","definition":"An acute hypersensitive immune response that occurs from exposure to an allergen. It results from the release of histamine and histamine-like substances from mast cells, and can present with breathing difficulty due to narrowed airways, dizziness and hypotension, skin rash, weak pulse, nausea and vomiting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F37AF06-7374-3F40-E053-F662850AB0B7","latestVersionIndicator":"Yes","beginDate":"2019-01-11","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-11","modifiedBy":"ONEDATA","dateModified":"2019-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7F37AF06-738F-3F40-E053-F662850AB0B7","beginDate":"2019-01-11","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-11","modifiedBy":"ONEDATA","dateModified":"2019-01-11","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2757951","version":"1","preferredName":"Other","longName":"2757951","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F52A8FB-E278-3426-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":"Added concept to value meaning. mc 3/20/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7F37AF06-7399-3F40-E053-F662850AB0B7","beginDate":"2019-01-11","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-11","modifiedBy":"ONEDATA","dateModified":"2019-01-11","deletedIndicator":"No"},{"value":"Dehydration","valueDescription":"Dehydration","ValueMeaning":{"publicId":"2946354","version":"1","preferredName":"Dehydration","longName":"2946354","preferredDefinition":"A condition resulting from the excessive loss of water from the body. It is usually caused by severe diarrhea, vomiting or diaphoresis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dehydration","conceptCode":"C26740","definition":"A condition resulting from the excessive loss of water from the body. It is usually caused by severe diarrhea, vomiting or diaphoresis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746D32D6-F8C8-1467-E040-BB89AD436E21","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7F37AF06-73A3-3F40-E053-F662850AB0B7","beginDate":"2019-01-11","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-11","modifiedBy":"ONEDATA","dateModified":"2019-01-11","deletedIndicator":"No"},{"value":"Vomiting","valueDescription":"Vomiting","ValueMeaning":{"publicId":"4395791","version":"1","preferredName":"Vomiting","longName":"4395791","preferredDefinition":"Forceful ejection of the contents of the stomach through the mouth.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vomiting","conceptCode":"C3442","definition":"Forceful ejection of the contents of the stomach through the mouth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-DBF3-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7F37AF06-73AD-3F40-E053-F662850AB0B7","beginDate":"2019-01-11","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-11","modifiedBy":"ONEDATA","dateModified":"2019-01-11","deletedIndicator":"No"},{"value":"Nausea","valueDescription":"Nausea","ValueMeaning":{"publicId":"5040701","version":"1","preferredName":"Nausea","longName":"5040701","preferredDefinition":"Upper abdominal discomfort associated with an urge to vomit.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nausea","conceptCode":"C3258","definition":"Upper abdominal discomfort associated with an urge to vomit.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2354E479-8671-0992-E050-BB89AD433614","latestVersionIndicator":"Yes","beginDate":"2015-10-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7F37AF06-73B7-3F40-E053-F662850AB0B7","beginDate":"2019-01-11","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-11","modifiedBy":"ONEDATA","dateModified":"2019-01-11","deletedIndicator":"No"},{"value":"Elevated liver enzymes","valueDescription":"Abnormal Liver Function Test","ValueMeaning":{"publicId":"6608494","version":"1","preferredName":"Abnormal Liver Function Test","longName":"6608494","preferredDefinition":"Atypical results found on serum liver enzyme testing, which may indicate significant disease and/or disease progression.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Abnormal Liver Function Test","conceptCode":"C122516","definition":"Atypical results found on serum liver enzyme testing, which may indicate significant disease and/or disease progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F37AF06-73C4-3F40-E053-F662850AB0B7","latestVersionIndicator":"Yes","beginDate":"2019-01-11","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-11","modifiedBy":"ONEDATA","dateModified":"2019-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7F37AF06-73DF-3F40-E053-F662850AB0B7","beginDate":"2019-01-11","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-11","modifiedBy":"ONEDATA","dateModified":"2019-01-11","deletedIndicator":"No"},{"value":"Diarrhea","valueDescription":"Diarrhea","ValueMeaning":{"publicId":"4395762","version":"1","preferredName":"Diarrhea","longName":"4395762","preferredDefinition":"Watery bowel movements.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diarrhea","conceptCode":"C2987","definition":"Watery bowel movements.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-D82F-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7F37AF06-73E9-3F40-E053-F662850AB0B7","beginDate":"2019-01-11","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-11","modifiedBy":"ONEDATA","dateModified":"2019-01-11","deletedIndicator":"No"},{"value":"Infection","valueDescription":"Infection","ValueMeaning":{"publicId":"6610519","version":"1","preferredName":"Infection","longName":"6610519","preferredDefinition":"The invasion of an organism's body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Infection","conceptCode":"C128320","definition":"The invasion of an organism's body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F7FD6EF-C887-4DB3-E053-F662850AB340","latestVersionIndicator":"Yes","beginDate":"2019-01-15","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-01-15","modifiedBy":"ONEDATA","dateModified":"2019-01-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AEFF3AD8-DB8F-172B-E053-4EBD850AE2BE","beginDate":"2020-09-10","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-10","modifiedBy":"ONEDATA","dateModified":"2020-09-10","deletedIndicator":"No"},{"value":"Renal dysfunction","valueDescription":"Renal Dysfunction","ValueMeaning":{"publicId":"7415464","version":"1","preferredName":"Renal Dysfunction","longName":"7415464","preferredDefinition":"Of or pertaining to the kidney.: Disturbance, impairment or abnormality of function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Renal","conceptCode":"C25225","definition":"Of or pertaining to the kidney.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Dysfunction","conceptCode":"C53526","definition":"Disturbance, impairment or abnormality of function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF0C2512-61E4-3689-E053-4EBD850A6A69","latestVersionIndicator":"Yes","beginDate":"2020-09-11","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-11","modifiedBy":"TAYLORT","dateModified":"2020-09-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AF0C2512-61FD-3689-E053-4EBD850A6A69","beginDate":"2020-09-11","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-11","modifiedBy":"ONEDATA","dateModified":"2020-09-11","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F37AF06-7290-3F40-E053-F662850AB0B7","latestVersionIndicator":"Yes","beginDate":"2019-01-11","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-11","modifiedBy":"TAYLORT","dateModified":"2020-09-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"If Non-Hematologic Toxicity,","type":"Preferred Question Text","description":"If Non-Hematologic Toxicity, specify:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F3156BC-250A-2A02-E053-F662850AC41F","latestVersionIndicator":"Yes","beginDate":"2019-01-11","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-11","modifiedBy":"STARGELM","dateModified":"2020-09-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}